Hear from the exciting companies completing the first Relevant Health cohort! This event is currently invite only, but if you would like to find out more and possibly attend please send an email to info@relevanthealth.md
To find out more about the cohort, visit http://www.relevanthealth.md/companies.html
You thought the Shark Tank was tough… wait until you enter the the first annual Maryland Crab Trap!
Submit your application to our business plan competition for a chance to be named the company with the most commercial potential at the Regional Biotech Forum and have the opportunity to win $10,000 and an incubation space! Pitch your idea to industry experts on April 19th and 5 Finalists will have the chance to win the Grand Prize. This competition will be focused on companies in the following sectors: Therapeutics, Diagnostics, Medical Devices, Healthcare Services, E-Health, Mobile Health, Electronic Medical Records, Health Informatics, and BioHealth Cyber Security.
Companies will be scored on: Product, Technical Feasibility, Marketing/Strategy, and Leadership team.
Deadline for entries is March 25th – Finalists will be announced by April 4th -Regional Biotech Forum Event: Panel Presentation is on April 18th
Medical device company Senseonics Holdings Inc. raised about $45 million last week in the first Greater Washington IPO of the year.
Senseonics (NYSE: SENS) originally planned to raise about $60 million by offering 18.2 million shares at a range of $3.10 to $3.50, but ultimately lowered the proposed deal size for the IPO.
GlaxoSmithKline (GSK) and Miltenyi Biotech said they will partner to develop new cell and gene therapies through a collaboration whose value was not disclosed.
The collaboration is designed to combine GSK’s expertise in developing cell- and gene therapy–based treatments with Miltenyi Biotec’s global leadership in cell processing and related technologies in cell therapy, the companies said.
Economic Alliance of Greater Baltimore CEO Thomas Sadowski has taken a high-ranking economic development position with the state’s public university system.
Sadowski, who has headed the business advocacy group known as the EAGB since 2008, is becoming the vice chancellor for economic development at the University System of Maryland. He’ll start May 2 at the public education system, which is made up of a dozen institutions with 163,000 students.
Blueprint Medicines is collaborating with Roche on the discovery, development and commercialisation of up to five targeted cancer immunotherapies, in a deal potentially worth more than $1 billion.
March is Women’s History Month. To honor this special time, WIB-DC/Baltimore presents an educational event on the topic of financing with biotech entrepreneurs Wendy Perrow, M.B.A. (CEO at Alba Therapeutics) and Audra Stinchcomb, Ph.D. (CSO and Founder of F6 Pharma), who will share their knowledge and experience with funding a biotech enterprise. Entrepreneur Iris Sherman, M.B.A. (President and Cofounder of Kitchology) will serve as moderator for this discussion.
Every year TEDCO makes dozens of investments in the State’s most promising tech startups – this volume of deal flow makes TEDCO the “go to” seed stage funding source for Maryland entrepreneurs.
You may have heard about TEDCO’s TCF (Technology Commercialization Fund) and CIF (Cybersecurity Investment Fund) Programs and found yourself wondering “What are they?”, “What is TEDCO looking for?”, and “How can I maximize my chance of getting funded? – well…now help is on the way!!
Join us for an “entrepreneur only” workshop to learn how you can prepare a powerful application for these two TEDCO flagship funding programs. The first part of the workshop will cover the TCF/CIF process, application requirements and the key points every reviewer is looking for in an application. In the second half, entrepreneurs will have the chance to discuss their specific situations & questions with experienced TEDCO review committee members.
Montgomery County’s Bethesda Hyatt will be the venue for the CONNECTpreneur XVIII Forum on April 28. The event, which will be held 7:00 to 11:00 am, features a “fireside chat” with serial entrepreneur and CEO Mark Walsh.
With more than 250 CXO’s and investors, along with a strong lineup of speakers and presenters, the Big Idea CONNECTpreneur XVIII Forum is shaping up to be a record-setting event.
Virginia Bio, the premier statewide non-profit association representing life science industry in the Commonwealth of Virginia, elected Dr. Reg Seeto, Vice President, Head of Partnering and Strategy at MedImmune, the biologics research and development arm of AstraZeneca, as a new member of their Board of Directors for a term of three years.
Venture capitalists had a big year in Maryland in 2015.
In the fourth quarter of last year, they invested more than $451 million in 14 different Maryland companies — the largest quarter ever in the state since 2006.
While most agencies try to imitate advances in the private sector, the Department of Health and Human Services instead is emulating the process that fuels many recent innovations: startup accelerators.
The White House on Friday appointed an executive director of its Cancer Moonshot Task Force: Gregory C. Simon, a leukemia survivor with experience in government, nonprofits, and the corporate world.
Entrepreneur Vivek Garipalli has a dim view of the way health insurance companies treat providers and patients. Patients develop trust with doctors and hospitals, and he thought insurers should be the “glue” between them instead of creating friction.
Microscopic robots, powered by bacterial flagellation, are a curious branch of robotics research, potentially leading to devices that can deliver drugs, perform surgical tasks, and help out with diagnostics. While bacteria has been harnessed in the past to power small devices, having those devices actually navigate to a desired target has been a challenge. At Drexel University researchers are now using electric fields to help their bacterial biobots detect obstacles and float around them on their way to the final destination.
Johns Hopkins University graduate programs in nursing, education, medicine, and biomedical engineering remain among the best in the nation, according to the newest U.S. News & World Report rankings of “Best Graduate Schools.”
The list, released on Wednesday, moves the university’s School of Nursing master’s degree program up from a tie for second place last year to the No. 1 spot this year.
The biotech investment climate sank into deep insecurity by the close of 2015, as shown in EP Vantage‘s new “Pharma & Biotech 2015 in Review” report. The flutterings around companies raising capital, via venture capital or IPO, diminished – which invites a retrospective on the investment environment in years past. Perhaps this will help inform how cash-hungry companies will fare this year.
Whether you are talking to peers, competitors or investors, you as an active entrepreneur will be judged on your familiarity with today’s startup and funding jargon. I’m not recommending that you saturate your discussions with lingo, but responding with a blank stare once-too-often won’t convince anyone that you can build the next world-changing business or outpace the market.
Looks like ARCH Venture Partners is gearing up for its ninth fund, with aims to raise $400 million, according to a regulatory filing. The Chicago-based early stage venture firm has a deep history in tech and life sciences investments – with some notable recent plays like Illumina offshoot Grail, Harvard 3D printing spinout Voxel 8, and Doug Williams’ brainchild Codiak Biosciences.
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
